Dr. Zeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
204 raymond road
Marlboro, MA 01752Phone+1 508-281-1674- Is this information wrong?
Education & Training
Hartford HospitalResidency, Pathology-Anatomic and Clinical, 2005
Yale UniversityPhD, Post doctoral research, 2000 - 2003
Lehigh UniversityPhD, Pharmaceutical Chemistry, 1995 - 2000
Xi'an Jiaotong Medical UniversityClass of 1993
Clinical Trials
- Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma Start of enrollment: 2021 Jul 01
Publications & Presentations
PubMed
- 43 citationsmTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD levelHao Zeng, Bo Lu, Raffaella Zamponi, Zinger Yang, Kristie Wetzel, Joseph Loureiro, Sina Mohammadi, Martin Beibel, Sebastian Bergling, John S. Reece-Hoyes, Carsten Russ,...> ;Proceedings of the National Academy of Sciences of the United States of America. 2018 Oct 30
Journal Articles
- Adjuvants for Coronavirus VaccinesHao Zeng, MD, Frontiers in Immunology
- mTORC1 Signaling Suppresses Wnt/Β-catenin Signaling Through DVL-Dependent Regulation of Wnt Receptor FZD LevelHao Zeng, MD, Proceedings of the National Academy of Sciences
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
